127 related articles for article (PubMed ID: 38683512)
1. [Barriers and facilitators of colorectal cancer screening access].
Schenfeld Y; Schernenco J; Bellando MB; Robles M; Picardi G; Dopazo Danieli IM; Albanesi L; Reig ME; Esandi ME; Bruzzone A
Medicina (B Aires); 2024; 84(2):267-278. PubMed ID: 38683512
[TBL] [Abstract][Full Text] [Related]
2. Colorectal Cancer Screening in Ghana: Physicians' Practices and Perceived Barriers.
Lussiez A; Dualeh SHA; Dally CK; Opoku BK; Raghavendran K; Aitpillah F; Boateng E; Darkwah D; Gyasi-Sarpong KC; Kolars JC; Kwakye G
World J Surg; 2021 Feb; 45(2):390-403. PubMed ID: 33145608
[TBL] [Abstract][Full Text] [Related]
3. Physician-office vs home uptake of colorectal cancer screening using FOBT/FIT among screening-eligible US adults.
Chido-Amajuoyi OG; Sharma A; Talluri R; Tami-Maury I; Shete S
Cancer Med; 2019 Dec; 8(17):7408-7418. PubMed ID: 31637870
[TBL] [Abstract][Full Text] [Related]
4. Patterns and predictors of repeat fecal immunochemical and occult blood test screening in four large health care systems in the United States.
Singal AG; Corley DA; Kamineni A; Garcia M; Zheng Y; Doria-Rose PV; Quinn VP; Jensen CD; Chubak J; Tiro J; Doubeni CA; Ghai NR; Skinner CS; Wernli K; Halm EA
Am J Gastroenterol; 2018 May; 113(5):746-754. PubMed ID: 29487413
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal Adherence to Immunochemical Fecal Occult Blood Testing vs Guaiac-based FOBT in an Organized Colorectal Cancer Screening Program.
Benito L; Travier N; Binefa G; Vidal C; Espinosa J; Milà N; Garcia M
Cancer Prev Res (Phila); 2019 May; 12(5):327-334. PubMed ID: 30890542
[TBL] [Abstract][Full Text] [Related]
6. Barriers and facilitators of implementing a multicomponent intervention to improve faecal immunochemical test (FIT) colorectal cancer screening in primary care clinics, Alberta.
Adhikari K; Mah SS; Patterson M; Teare GF; Manalili K
BMJ Open Qual; 2024 May; 13(2):. PubMed ID: 38802268
[TBL] [Abstract][Full Text] [Related]
7. The cumulative risk of false-positive fecal occult blood test after 10 years of colorectal cancer screening.
Hubbard RA; Johnson E; Hsia R; Rutter CM
Cancer Epidemiol Biomarkers Prev; 2013 Sep; 22(9):1612-9. PubMed ID: 23868091
[TBL] [Abstract][Full Text] [Related]
8. Effect of an equal-access military health system on racial disparities in colorectal cancer screening.
Changoor NR; Pak LM; Nguyen LL; Bleday R; Trinh QD; Koehlmoos T; Learn PA; Haider AH; Goldberg JE
Cancer; 2018 Sep; 124(18):3724-3732. PubMed ID: 30207379
[TBL] [Abstract][Full Text] [Related]
9. Results of National Colorectal Cancer Screening Program in Croatia (2007-2011).
Katičić M; Antoljak N; Kujundžić M; Stamenić V; Skoko Poljak D; Kramarić D; Stimac D; Strnad Pešikan M; Samija M; Ebling Z
World J Gastroenterol; 2012 Aug; 18(32):4300-7. PubMed ID: 22969192
[TBL] [Abstract][Full Text] [Related]
10. Predictors of Colorectal Cancer Screening: Does Rurality Play a Role?
Ojinnaka CO; Choi Y; Kum HC; Bolin JN
J Rural Health; 2015; 31(3):254-68. PubMed ID: 25599819
[TBL] [Abstract][Full Text] [Related]
11. Reasons for never and intermittent completion of colorectal cancer screening after receiving multiple rounds of mailed fecal tests.
Green BB; BlueSpruce J; Tuzzio L; Vernon SW; Aubree Shay L; Catz SL
BMC Public Health; 2017 May; 17(1):531. PubMed ID: 28558663
[TBL] [Abstract][Full Text] [Related]
12. Participation in colorectal cancer screening: a review.
Vernon SW
J Natl Cancer Inst; 1997 Oct; 89(19):1406-22. PubMed ID: 9326910
[TBL] [Abstract][Full Text] [Related]
13. Faecal occult blood testing (FOBT)-based colorectal cancer screening trends and predictors of non-use: findings from the South Australian setting and implications for increasing FOBT uptake.
Todorov K; Wilson C; Sharplin G; Corsini N
Aust Health Rev; 2018 Feb; 42(1):45-52. PubMed ID: 28248632
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal adherence with fecal occult blood test screening in community practice.
Fenton JJ; Elmore JG; Buist DS; Reid RJ; Tancredi DJ; Baldwin LM
Ann Fam Med; 2010; 8(5):397-401. PubMed ID: 20843880
[TBL] [Abstract][Full Text] [Related]
15. The Chinese and Korean American immigrant experience: a mixed-methods examination of facilitators and barriers of colorectal cancer screening.
Jung MY; Holt CL; Ng D; Sim HJ; Lu X; Le D; Juon HS; Li J; Lee S
Ethn Health; 2018 Nov; 23(8):847-866. PubMed ID: 28277021
[TBL] [Abstract][Full Text] [Related]
16. Self-perceived Mental Health Status and Uptake of Fecal Occult Blood Test for Colorectal Cancer Screening in Canada: A Cross-Sectional Study.
Hategekimana C; Karamouzian M
Int J Health Policy Manag; 2016 Feb; 5(6):365-71. PubMed ID: 27285514
[TBL] [Abstract][Full Text] [Related]
17. Comparative effectiveness of a multifaceted intervention to improve adherence to annual colorectal cancer screening in community health centers: a randomized clinical trial.
Baker DW; Brown T; Buchanan DR; Weil J; Balsley K; Ranalli L; Lee JY; Cameron KA; Ferreira MR; Stephens Q; Goldman SN; Rademaker A; Wolf MS
JAMA Intern Med; 2014 Aug; 174(8):1235-41. PubMed ID: 24934845
[TBL] [Abstract][Full Text] [Related]
18. Primary care, economic barriers to health care, and use of colorectal cancer screening tests among Medicare enrollees over time.
Doubeni CA; Laiyemo AO; Young AC; Klabunde CN; Reed G; Field TS; Fletcher RH
Ann Fam Med; 2010; 8(4):299-307. PubMed ID: 20644184
[TBL] [Abstract][Full Text] [Related]
19. A randomized trial of direct mailing of fecal occult blood tests to increase colorectal cancer screening.
Church TR; Yeazel MW; Jones RM; Kochevar LK; Watt GD; Mongin SJ; Cordes JE; Engelhard D
J Natl Cancer Inst; 2004 May; 96(10):770-80. PubMed ID: 15150305
[TBL] [Abstract][Full Text] [Related]
20. Viewpoints of the target population regarding barriers and facilitators of colorectal cancer screening in the Czech Republic.
Kroupa R; Ondrackova M; Kovalcikova P; Dastych M; Pavlik T; Kunovsky L; Dolina J
World J Gastroenterol; 2019 Mar; 25(9):1132-1141. PubMed ID: 30863000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
